These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16729160)

  • 1. [Sustainability of Brazilian policy for access to antiretroviral drugs].
    Grangeiro A; Teixeira L; Bastos FI; Teixeira P
    Rev Saude Publica; 2006 Apr; 40 Suppl():60-9. PubMed ID: 16729160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to antiretroviral treatment in Latin American countries and the Caribbean.
    Chequer P; Cuchí P; Mazin R; García Calleja JM
    AIDS; 2002 Dec; 16 Suppl 3():S50-7. PubMed ID: 12685925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to antiretroviral drugs in Brazil.
    Galvão J
    Lancet; 2002 Dec; 360(9348):1862-5. PubMed ID: 12480377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives.
    Greco DB; Simão M
    AIDS; 2007 Jul; 21 Suppl 4():S37-45. PubMed ID: 17620751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ministry of Health's spending on drugs: program trends from 2002 to 2007.
    Vieira FS
    Rev Saude Publica; 2009 Aug; 43(4):674-81. PubMed ID: 19547800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program.
    do Lago RF; Costa Ndo R
    Cad Saude Publica; 2009 Oct; 25(10):2273-84. PubMed ID: 19851626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health care to HIV/AIDS patients in Brazil].
    Portela MC; Lotrowska M
    Rev Saude Publica; 2006 Apr; 40 Suppl():70-9. PubMed ID: 16729161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Federal funding of health policy in Brazil: trends and challenges.
    Machado CV; Lima LD; Andrade CL
    Cad Saude Publica; 2014 Jan; 30(1):187-200. PubMed ID: 24627025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.
    Ford N; Wilson D; Costa Chaves G; Lotrowska M; Kijtiwatchakul K
    AIDS; 2007 Jul; 21 Suppl 4():S21-9. PubMed ID: 17620749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?
    Meiners C; Sagaon-Teyssier L; Hasenclever L; Moatti JP
    PLoS One; 2011; 6(8):e23478. PubMed ID: 21858138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?
    Benzaken AS; Pereira GFM; Costa L; Tanuri A; Santos AF; Soares MA
    AIDS Res Ther; 2019 Aug; 16(1):19. PubMed ID: 31412889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 13. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.
    Dhamija P; Bansal D; Medhi B
    Curr HIV Res; 2009 Jul; 7(4):410-7. PubMed ID: 19601776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative analysis of outpatient costs in HIV treatment programs.
    Sarti FM; Nishijima M; Campino AC; Cyrillo DC
    Rev Assoc Med Bras (1992); 2012; 58(5):561-7. PubMed ID: 23090227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011.
    Luo J; Oliveira MA; Ramos MB; Maia A; Osorio-de-Castro CG
    BMC Public Health; 2014 Apr; 14():367. PubMed ID: 24735589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert communities and interest-formation in the Brazilian AIDS program.
    Lago RFD; Costa NDR
    Cien Saude Colet; 2017 May; 22(5):1479-1488. PubMed ID: 28538919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brazil and access to HIV/AIDS drugs: a question of human rights and public health.
    Galvão J
    Am J Public Health; 2005 Jul; 95(7):1110-6. PubMed ID: 15933238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exceptional circumstance drug dispensing: history and expenditures of the Brazilian Ministry of Health.
    Carias CM; Vieira FS; Giordano CV; Zucchi P
    Rev Saude Publica; 2011 Apr; 45(2):233-40. PubMed ID: 21412568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.